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Abstract
The development of an electroporation based transfection method for Plasmodium falciparum has
been very successful for the study of some genes but its efficiency remains very low. While
alternative approaches have been documented, electroporation of infected red blood cells
generally remains the method of choice for introducing DNA into P. falciparum. In this paper we
compare four published transfection techniques in their ability to achieve stable transfections.
Technology enabling the genetic manipulation of malaria
parasites has advanced greatly in recent years. Early suc-
cess with the transfection of rodent Plasmodium species [1]
was followed by the achievement of transient [2] and sta-
ble transfections in Plasmodium falciparum [3–5]. Today
transfection technology is instrumental in assessing
numerous aspects of P. falciparum biology, including gene
function [6] and protein targeting [7]. However, progress
in this area is still limited by poor transfection efficiencies
and by the number and type of genetic modifications that
can be achieved with current vectors. New vectors that per-
mit both positive and negative selection are becoming
available and will address many of the limitations of the
current vectors [8,9]. However, the length of time required
to obtain a stable transfection can still be rate-limiting.
Electroporation of infected red blood cells is generally the
method of choice for introducing DNA into P. falciparum.
Alternative approaches including the electroporation of
uninfected red blood cells to allow spontaneous uptake of
DNA [10] and the use of polyamidoamine dendrimers to
transfer DNA across membranes [11] have been investi-
gated in an effort to improve transfection efficiency. Each
of these alternative methods have been shown to result in
substantially higher levels of reporter signals than is
achieved with methods of direct electroporation. How-
ever it is not known if these techniques have an improved
efficiency in establishing stable transfections. Transient
transfection efficiency is believed to be some fifty times
higher than stable transfection, but is often of little value
to investigators performing transfections experiments
with P. falciparum.
In order to optimize transfection efficiency and establish-
ment of stable transfections we have compared four pub-
lished transfection techniques in their ability to achieve
stable transfection. These are the electroporation methods
of Wu et al [2] and Fiddock et al. [12], the spontaneous
uptake method of Deitsch et al [10] and the polyami-
doamine dendrimer method of Mamoun et al. [11] An
additional chemical transfection agent, Effectene (Qia-
gen) was also tested.
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Materials and Methods
Parasites
P. falciparum clone 3D7, obtained from D. Walliker (Uni-
versity of Edinburgh, Edinburgh UK), was cultured as
described [13] and cultures containing 10% ring stage par-
asites were used for all transfection experiment. The exper-
imental drug WR99210 (Jacobus Pharmaceutical
Company, New Jersey) was use to select for parasites con-
taining plasmid. The growth and development of each
transfection was monitored by Giemsa stained thin
smears. Cultures in which drug resistant parasites could
be detected before day 31 post transfection were consid-
ered to be stably transfected.
Construction of the plasmid vector pHH1-DAG and DNA 
preparation
The P. falciparum expression vector pHH1 [14] was used to
construct a pHH1-DAG knockout plasmid for use in all
experiments. In this vector, the T. gondii dhfr-ts is replaced
with the human dhfr  mutated to encode resistance to
WR99210 [12]. The transfection construct pHH1-DAG
was made using oligonucleotides 4137D-X5' (GACTC-
GAGGCCAACTCGAAACTTCCTGC) and 4137E-X5'
(GACTCGAGCATCTTTTGCTTGCGGCCGG) to generate
an 899 bp PCR product corresponding to part of a gene on
the right arm of chromosome 9, (PlasmoDB identifier PFI
1735c) but missing both the 3' and 5' regions. The pHH1
vector was digested with Xho1 and Bgl1 to release the
hsp86 upstream regulatory sequence, the Xho1 and Bgl1
ends were then "filled " and the 899 bp PCR product blunt
end cloned into this site to create the vector pHH1-DAG.
The plasmid was propagated in PMC103 cells and pre-
pared using Qiagen Mega Prep columns. Sufficient plas-
mid was prepared for all experiments, pooled and stored
at -70°C until required.
Transfection methods
In order to make all transfection experiments as compara-
ble as possible, red blood cells were drawn from a single
donor 2–3 hours prior to the transfection being per-
formed. The same donor was used for all experiments. All
plasmid used was from a single plasmid pool (see above).
While it was not possible to carry out all transfections
simultaneously, strict monitoring ensured that all trans-
fections were maintained under the same environmental
conditions.
Spontaneous Uptake of DNA from erythrocytes
The method is essentially as described [10]. Briefly, a 240
µl aliquot of erythrocytes was washed 3 times in RPMI
1640 and once in 5 mls cytomix [2]. Fifty µg of DNA was
added with cytomix to give a final volume of 400 µl. The
cells were transferred to a 0.2 cm cuvette, chilled on ice
and electroporated using a Bio-Rad gene pulser and 0.31
kV, 960 µf. After electroporation the erythrocytes were
washed once with RPMI 1640 and resuspended to a 5%
haematocrit in complete culture media. A 4.5 ml aliquot
of this suspension was dispensed into a 150 mm petri dish
and inoculated with 0.5 mls of parasite culture. The cul-
ture was diluted with DNA loaded RBC's as required until
drug pressure was applied on day 6 post transfection and
maintained at 5 µm WR99210 thereafter.
Electroporation method 1
The method was essentially as described by Wu et al. [2].
Briefly, parasitized red blood cells were pelleted and resus-
pended in cytomix containing 150 µg DNA to give a final
volume of 800 µl. Electroporations were carried out in 0.4
cm cuvettes using settings of 2.5 kV, 25 µf. Electroporated
samples were immediately mixed with 30 mls complete
culture media and fresh RBC's added to give a 5% haema-
tocrit in a 150 mm petri dish. Cultures were maintained
without drug pressure for 48 hours and then maintained
on 5 µm WR99210 thereafter
Electroporation method 2
The method was essentially as described by Fidock and
Wellems [12]. Briefly, parasitized red blood cells were pel-
leted and resuspended in cytomix containing 150 µg DNA
to give a final volume of 800 µl. Electroporations were car-
ried out in 0.4 cm cuvettes using settings of 0.31 kV and
960 µf. Electroporated samples were immediately mixed
with 30 mls complete culture media and fresh RBCs
added to give a 5% haematocrit in a 150 mm petri dish.
Cultures were maintained without drug pressure for 48
hours and then maintained on 5 µm WR99210 thereafter
Chemical Transfection method 1 (Superfect)
The method is essentially as described by Mamoun et al.
[11] and the manufacturer (Qiagen). 10 µ DNA was incu-
bated with 40 µl superfect reagent for 10 mins and then
mixed with 1 ml of complete culture media. This mix was
then added drop wise to 240 µl packed parasitized red
blood cells. Cultures were maintained for 48 hours with-
out drug pressure and were diluted with fresh red blood
cells when required.
Chemical Transfection method 2 (Effectene)
This method was carried out according to the manufactur-
ers instructions (Qiagen), 2 µg DNA was mixed with
buffer EC to a volume of 300 µl, 16 µl of enhancer was
added and the mix incubated for 5 mins at room temper-
ature. 60 µl of Effectene reagent was added to the mix and
incubated for a further 10 mins before the addition of 1
ml complete culture medium. This DNA mix was then
added drop wise to 240 µl packed parasitized red blood
cells. After DNA addition 4.5 ml of complete media was
added to the cells. Cultures were maintained for 48 hours
without drug pressure and were diluted with fresh red
blood cells when required.Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/19
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Results and Discussion
All transfections performed using the high voltage/low
capacitance method of Wu et al. [2] resulted in stable
transfection (Table 1). However, only one of four transfec-
tions performed using the low voltage/high capacitance
method of Fiddock et al. [12] was successful. This con-
trasts with previous findings [12] and may be because in
previous studies the success of transfection was measured
by expression of a reporter gene, whereas we only consid-
ered a transfection to be successful if continuous growth
of parasites after drug selection was achieved. Differences
in viability post-electroporation are not believed to be
responsible for the different transfection efficiencies of
these 2 protocols as no difference in parasite growth was
observed. We acknowledge that other factors relating to
red cells, parasites, vectors or equipment may have con-
tributed to the observed differences, investigating these
factors was beyond the scope of this study.
The spontaneous uptake method of Deitsch et al. [10] was
the most successful of all the methods assessed. All four
cultures transfected using this technique grew out after
drug selection. This technique was labour intensive,
requiring the addition of DNA loaded red blood cells for
several days before drug selection. However, as fewer par-
asites were required, less media and other consumables
were needed. The electroporation of uninfected red cells
rather than the parasites themselves is likely to be an
important factor in the success of this method as it has no
impact on parasite viability. This technique has also been
shown to be successful in achieving stable transfections
with smaller amounts of DNA than the 200 µg used here
making this method of transfection extremely favourable.
Success with the SuperFect method has been previously
repored [11] and the protocol used during this study was
essentially as described, however we were unable to use
either the SuperFect or Effectene reagent to generate stable
transfectants. Optimization experiments with both the
SuperFect and the Effectene protocols may be the key to
improving transfection efficiencies with these chemical
reagents, however, the very nature of these products and
their method of DNA delivery suggests that they may be of
limited value in this area of research.
Table 1: In vitro efficacy of P. falciparum transfection techniques.
Method of Transfection Parasite Positive (Day) 1% Parasitaemia (Day) Success Rate (%)
Spontaneous Uptake (Deitsch et al. 2001) 100%
Transfection 1 19 24
Transfection 2 16 C
Transfection 3 19 24
Transfection 4 17 24
Average 18 24
Electroporation A (Wu et al. 1995) 100%
Transfection 1 30 36
Transfection 2 30 37
Transfection 3 17 20
Transfection 4 16 19
Average 23 28
Electroporation B (Fiddock et al. 1997) 25%
Transfection 1 N/A N/A
Transfection 2 N/A N/A
Transfection 3 16 19
Transfection 4 N/A N/A
SuperFect (Mamoun et al. 1999) 0%
Transfection 1 N/A N/A
Transfection 2 N/A N/A
Effectene 0%
Transfection 1 N/A N/A
Transfection 2 N/A N/A
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Conclusions
Genetic manipulation of P. falciparum relies on transfec-
tion techniques which have a low level of efficiency and
multiple transfections are often required before a stable
transfection can be established. We have examined estab-
lished and novel transfection techniques in order to deter-
mine the method most likely to result in stable
transfections. Our data suggest that electroporation is the
best method to deliver DNA into these parasites and that
the spontaneous uptake protocol of Deitsch et al. [10]
may be the most efficient of those currently in use.
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